Back
Kymera Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
70
KYMR
Kymera Therapeutics, Inc.
Last Price:
$81.31
Seasonality Move:
-9.68%
7 Day Trial
ALL ACCESS PASS
$
7
Kymera Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Kymera Therapeutics, Inc. has on average historically risen by 15.8% based on the past 5 years of stock performance.
-
Kymera Therapeutics, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Kymera Therapeutics, Inc. Stock Undervalued?The current Kymera Therapeutics, Inc. [KYMR] share price is $81.32. The Score for KYMR is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Kymera Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Kymera Therapeutics, Inc. has on average historically risen by 15.8% based on the past 5 years of stock performance.
Kymera Therapeutics, Inc. Stock Rating
Buy
70
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. overpriced?
-
Kymera Therapeutics, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Kymera Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kymeratx.com
52-Week Data
52-Week High:
103.00
52-Week Low:
19.45
Prediction Charts
Market Cap:
5.9B
Price in USD:
81.32
Volume:
418.6K
Beta:
2.20
Technical Analysis
SMA50:
69.02
SMA100:
58.54
SMA200:
47.63
52-Wk Change:
93.53%
Stock Predictions
-
Is Kymera Therapeutics, Inc. stock public?Yes, Kymera Therapeutics, Inc. is a publicly traded company.
-
What is the Kymera Therapeutics, Inc. stock quote today?The Kymera Therapeutics, Inc. stock price is 81.32 USD today.
-
How to buy Kymera Therapeutics, Inc. stock online?You can buy Kymera Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-8 | 89.17 | 94.30 | 103.00 | 86.61 |
| Dec-9 | 90.72 | 86.88 | 91.10 | 85.00 |
| Dec-10 | 93.07 | 89.89 | 93.82 | 86.37 |
| Dec-11 | 90.74 | 87.81 | 91.71 | 86.23 |
| Dec-12 | 90.09 | 89.68 | 91.38 | 86.35 |
| Dec-15 | 87.58 | 85.68 | 90.33 | 84.58 |
| Dec-16 | 86.32 | 84.19 | 87.42 | 84.05 |
| Dec-17 | 83.36 | 82.07 | 84.23 | 80.78 |
| Dec-18 | 83.00 | 79.63 | 83.70 | 77.78 |
| Dec-19 | 81.20 | 83.99 | 84.64 | 81.20 |
| Dec-22 | 84.73 | 84.35 | 85.41 | 82.87 |
| Dec-23 | 83.58 | 83.53 | 85.15 | 82.55 |
| Dec-24 | 83.74 | 83.13 | 84.83 | 82.67 |
| Dec-26 | 82.47 | 81.32 | 82.86 | 81.04 |
Kymera Therapeutics, Inc. Earnings
Kymera Therapeutics, Inc. Earnings Report: Per Share Kymera Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Kymera Therapeutics, Inc. Forecast Revenue Growth
Kymera Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Kymera Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.62 per share, and a decrease next year of $0.25 per share.
* Kymera Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.